CN210711901U - Antibacterial and bacteriostatic woven fabric - Google Patents
Antibacterial and bacteriostatic woven fabric Download PDFInfo
- Publication number
- CN210711901U CN210711901U CN201920720985.3U CN201920720985U CN210711901U CN 210711901 U CN210711901 U CN 210711901U CN 201920720985 U CN201920720985 U CN 201920720985U CN 210711901 U CN210711901 U CN 210711901U
- Authority
- CN
- China
- Prior art keywords
- antibacterial
- fibers
- bacteriostatic
- woven fabric
- cellulose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- D—TEXTILES; PAPER
- D03—WEAVING
- D03D—WOVEN FABRICS; METHODS OF WEAVING; LOOMS
- D03D13/00—Woven fabrics characterised by the special disposition of the warp or weft threads, e.g. with curved weft threads, with discontinuous warp threads, with diagonal warp or weft
-
- D—TEXTILES; PAPER
- D03—WEAVING
- D03D—WOVEN FABRICS; METHODS OF WEAVING; LOOMS
- D03D15/00—Woven fabrics characterised by the material, structure or properties of the fibres, filaments, yarns, threads or other warp or weft elements used
-
- D—TEXTILES; PAPER
- D03—WEAVING
- D03D—WOVEN FABRICS; METHODS OF WEAVING; LOOMS
- D03D15/00—Woven fabrics characterised by the material, structure or properties of the fibres, filaments, yarns, threads or other warp or weft elements used
- D03D15/20—Woven fabrics characterised by the material, structure or properties of the fibres, filaments, yarns, threads or other warp or weft elements used characterised by the material of the fibres or filaments constituting the yarns or threads
- D03D15/208—Woven fabrics characterised by the material, structure or properties of the fibres, filaments, yarns, threads or other warp or weft elements used characterised by the material of the fibres or filaments constituting the yarns or threads cellulose-based
- D03D15/217—Woven fabrics characterised by the material, structure or properties of the fibres, filaments, yarns, threads or other warp or weft elements used characterised by the material of the fibres or filaments constituting the yarns or threads cellulose-based natural from plants, e.g. cotton
-
- D—TEXTILES; PAPER
- D03—WEAVING
- D03D—WOVEN FABRICS; METHODS OF WEAVING; LOOMS
- D03D15/00—Woven fabrics characterised by the material, structure or properties of the fibres, filaments, yarns, threads or other warp or weft elements used
- D03D15/20—Woven fabrics characterised by the material, structure or properties of the fibres, filaments, yarns, threads or other warp or weft elements used characterised by the material of the fibres or filaments constituting the yarns or threads
- D03D15/208—Woven fabrics characterised by the material, structure or properties of the fibres, filaments, yarns, threads or other warp or weft elements used characterised by the material of the fibres or filaments constituting the yarns or threads cellulose-based
- D03D15/225—Woven fabrics characterised by the material, structure or properties of the fibres, filaments, yarns, threads or other warp or weft elements used characterised by the material of the fibres or filaments constituting the yarns or threads cellulose-based artificial, e.g. viscose
Abstract
The utility model discloses an antibiotic antibacterial machine is weaved, including the cloth body, the cloth body includes warp layer and weft layer, the warp layer comprises warp direction yarn, the weft layer is formed by standing grain cellulose fiber and other fibre blending or comprises single standing grain cellulose long filament, standing grain cellulose fiber and other fibrous blending ratio is 30:70 or 40: 60. The scheme selects the cellulose fibers and the natural fibers for blending, eliminates the harm to human bodies in the dyeing and finishing process, simultaneously makes full use of the antibacterial and bacteriostatic effects of the cellulose fibers, avoids the defects of heat intolerance, large dyeing difficulty and poor cohesion of the cellulose fibers, and provides a good way for the application of the cellulose fibers.
Description
Technical Field
The utility model relates to the technical field of cloth, especially, relate to an antibiotic antibacterial machine is weaved.
Background
In daily life, the climate in clothes and bedding can create good conditions for the breeding and propagation of bacteria, the bacteria comprise staphylococcus aureus, escherichia coli and the like, as textiles are an important medium for transferring pathogenic bacteria, people inevitably contact with bacteria in daily life, certain pathological stimulation is generated, sweat and sebum secreted by human bodies can generate peculiar smells such as ammonia gas and the like due to the decomposition effect of the bacteria, and the peculiar smells can increase a lot of troubles for our life through skin or breathing and cause great harm to human health, so that the clothes and bedding with the antibacterial and bacteriostatic functions are produced.
At present, the mainstream treatment modes of the antibacterial and bacteriostatic woven fabric in the market are two, one mode is a built-in silver ion antibacterial and bacteriostatic fabric, the antibacterial and bacteriostatic agent is directly prepared into chemical fibers by adopting a spinning-grade antibacterial and bacteriostatic technology, and the other mode is a post-treatment technology, namely the antibacterial and bacteriostatic agent is added through a subsequent shaping process of the fabric.
The technology has the following defects when preparing the antibacterial and bacteriostatic woven fabric: the nano silver ions are not firmly fixed in the textile, the antibacterial and bacteriostatic effects are not generated after washing twice, and in addition, the nano silver ions are harmful to the human body, so the existing antibacterial and bacteriostatic woven fabric needs to be improved.
SUMMERY OF THE UTILITY MODEL
The utility model aims at solving the insecure adhesion of the nano silver ions in the textile fabric existing in the prior art, washing twice has no antibacterial and bacteriostatic effect, and the nano silver ions have the defect of injury to the human body, and the provided antibacterial and bacteriostatic machine is woven.
In order to achieve the above purpose, the utility model adopts the following technical scheme:
the antibacterial and bacteriostatic woven fabric comprises a fabric body, wherein the fabric body comprises a warp layer and a weft layer, the warp layer is composed of warp yarns, the weft layer is formed by blending cereal cellulose fibers and other fibers or is composed of single cereal cellulose filaments, and the blending ratio of the cereal cellulose fibers to the other fibers is 30:70 or 40: 60.
Preferably, the warp yarns are any one of combed pure cotton yarns, tencel yarns and modal yarns.
Preferably, the other fiber is any one of combed pure cotton yarn, tencel fiber and modal.
Preferably, the yarn count of the cloth body is 40 and 150D filaments or 50 and 150D filaments.
Preferably, the fabric weave of the cloth body adopts 2/1 twill weave or 3/1 twill weave.
Compared with the prior art, the beneficial effects of the utility model reside in that:
the scheme selects the cellulose fibers and the natural fibers for blending, eliminates the harm to human bodies in the dyeing and finishing process, simultaneously makes full use of the antibacterial and bacteriostatic effects of the cellulose fibers, avoids the defects of heat intolerance, large dyeing difficulty and poor cohesion of the cellulose fibers, and provides a good way for the application of the cellulose fibers.
Drawings
Fig. 1 is a schematic layered view of a fabric body of the antibacterial and bacteriostatic woven fabric of the utility model.
In the figure: 1 cloth body, 2 warp layers and 3 weft layers.
Detailed Description
The technical solutions in the embodiments of the present invention will be described clearly and completely with reference to the accompanying drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only some embodiments of the present invention, not all embodiments.
In the description of the present invention, it is to be understood that the terms "upper", "lower", "front", "rear", "left", "right", "top", "bottom", "inner", "outer", and the like indicate orientations or positional relationships based on the orientations or positional relationships shown in the drawings, and are only for convenience of description and simplicity of description, and do not indicate or imply that the device or element being referred to must have a particular orientation, be constructed and operated in a particular orientation, and therefore, should not be construed as limiting the present invention.
Referring to fig. 1, the antibacterial woven fabric comprises a fabric body 1, wherein the fabric body 1 comprises a warp yarn layer 2 and a weft yarn layer 3, the warp yarn layer 2 is composed of warp yarns, the weft yarn layer 3 is formed by blending of cellulose fibers and other fibers or is composed of single cellulose filaments, and the blending ratio of the cellulose fibers to the other fibers is 30:70 or 40: 60.
The warp yarns are any one of combed pure cotton yarns, tencel yarns and Modal yarns.
The other fiber is any one of combed pure cotton yarn, tencel fiber and modal.
The yarn count of the cloth body 1 is 40 and 150D filaments or 50 and 150D filaments.
The fabric weave of the cloth body 1 adopts 2/1 twill weave or 3/1 twill weave.
The cellulose fiber is a degradable biological high molecular material which takes natural plant raw materials as main raw materials, utilizes a biological fermentation engineering technology, adopts water phase extraction and does not contain any chemical solvent, and the raw material is corn, so that the defects that nano-silver in the traditional sense is not firmly fixed in weaving and has no antibacterial and bacteriostatic effects after being washed for one time or two times are overcome.
The above, only be the concrete implementation of the preferred embodiment of the present invention, but the protection scope of the present invention is not limited thereto, and any person skilled in the art is in the technical scope of the present invention, according to the technical solution of the present invention and the utility model, the concept of which is equivalent to replace or change, should be covered within the protection scope of the present invention.
Claims (5)
1. The antibacterial and bacteriostatic woven fabric comprises a fabric body (1), and is characterized in that the fabric body (1) comprises a warp yarn layer (2) and a weft yarn layer (3), wherein the warp yarn layer (2) is formed by warp yarns, and the weft yarn layer (3) is formed by blending cellulose fibers and other fibers or is formed by single cellulose filaments.
2. The antibacterial woven fabric according to claim 1, wherein the warp yarns are any one of combed pure cotton yarns, tencel yarns and modal yarns.
3. An antibacterial woven fabric according to claim 1, wherein the other fibers are any one of combed pure cotton yarn, tencel fiber and modal.
4. The antibacterial woven fabric according to claim 1, wherein the yarn count of the fabric body (1) is 40 and 150D filaments or 50 and 150D filaments.
5. The antibacterial woven fabric according to claim 1, wherein the fabric weave of the fabric body (1) adopts 2/1 twill weave or 3/1 twill weave.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201920720985.3U CN210711901U (en) | 2019-05-20 | 2019-05-20 | Antibacterial and bacteriostatic woven fabric |
PCT/CN2020/091287 WO2020233597A1 (en) | 2019-05-20 | 2020-05-20 | Antibacterial and bacteriostatic machine woven fabric |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201920720985.3U CN210711901U (en) | 2019-05-20 | 2019-05-20 | Antibacterial and bacteriostatic woven fabric |
Publications (1)
Publication Number | Publication Date |
---|---|
CN210711901U true CN210711901U (en) | 2020-06-09 |
Family
ID=70966078
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201920720985.3U Active CN210711901U (en) | 2019-05-20 | 2019-05-20 | Antibacterial and bacteriostatic woven fabric |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN210711901U (en) |
WO (1) | WO2020233597A1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6905987B2 (en) * | 2001-03-27 | 2005-06-14 | The Procter & Gamble Company | Fibers comprising polyhydroxyalkanoate copolymer/polylactic acid polymer or copolymer blends |
US20180002835A1 (en) * | 2015-01-29 | 2018-01-04 | University Of Connecticut | Composite fibers and matrices thereof |
CN107385541A (en) * | 2016-05-17 | 2017-11-24 | 宁波禾素纤维有限公司 | Application of the PHBV materials as new type natural antiseptic in textile preparation |
CN110029445A (en) * | 2019-05-13 | 2019-07-19 | 南京怡康抗菌材料科技有限公司 | A kind of antibacterial bacteriostatic spunlace non-woven cloth |
-
2019
- 2019-05-20 CN CN201920720985.3U patent/CN210711901U/en active Active
-
2020
- 2020-05-20 WO PCT/CN2020/091287 patent/WO2020233597A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2020233597A1 (en) | 2020-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103194847A (en) | Antibacterial, moisture-absorbent and warming knitted fabric and manufacturing method thereof | |
CN113172956A (en) | Antibacterial crease-resistant knitted fabric and preparation method thereof | |
CN210501766U (en) | Bamboo fiber blended fabric | |
CN110029427A (en) | A kind of antibacterial bacteriostatic woven fabric | |
CN211641256U (en) | Knitted jacquard fabric | |
CN202800955U (en) | Hua tuo silk fiber raschel woolen blanket | |
CN210711901U (en) | Antibacterial and bacteriostatic woven fabric | |
CN104060369A (en) | Antibacterial health-care fabric | |
CN203333924U (en) | Antiseptic breathable lining cloth | |
CN114045603B (en) | Antibacterial and breathable fabric and processing technology thereof | |
CN202727436U (en) | Organic cotton fiber textile fabric | |
CN210911455U (en) | Semi-combed silk and wool blended knitting yarn fabric with good antibacterial effect | |
CN212372873U (en) | Antibacterial, moisture-absorbing and breathable rib knitted fabric | |
CN215906351U (en) | Moisture-absorbing and quick-drying blended knitted fabric made of cellulose fibers and viscose-based sarcandra glabra fibers | |
CN217671513U (en) | Composite antibacterial polyester-ammonia fabric | |
CN202079862U (en) | Bamboo fiber anionic plus material | |
CN213704766U (en) | Wear-resistant and bactericidal composite textile fabric | |
CN219856278U (en) | Tearing-resistant soft fabric | |
CN218043803U (en) | Underpants with silver ion antibacterial function | |
CN212737328U (en) | Skin-tendering antibacterial knitted rib fabric | |
CN217455154U (en) | Three-dimensional dacron warp knitting wire drawing surface fabric is stabilized in resistance to compression | |
CN217399076U (en) | Antibacterial polyester yarn | |
CN219055595U (en) | High-strength banana fiber fabric | |
CN212316360U (en) | Air layer functional fabric | |
CN212293954U (en) | Woolen sweater fabric |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: 210000 first floor, building 5, No. 33, Maqun street, Qixia District, Nanjing, Jiangsu Province Patentee after: Nanjing Hesu Times Antimicrobial Materials Technology Group Co.,Ltd. Address before: 210000 2nd floor, building 1, No. 33, Maqun street, Maqun street, Qixia District, Nanjing City, Jiangsu Province Patentee before: Nanjing Hesu times antibacterial material technology Co.,Ltd. |
|
CP03 | Change of name, title or address |